Prof. Douglas A Lauffenburger

Ford Foundation Professor of Bioengineering and Chemical Engineering
Chair, Computational and Systems Biology Initiative (CSBi) Steering Committee

Primary DLC

Department of Biological Engineering

MIT Room: 16-429

Areas of Interest and Expertise

Molecular Cell Bioengineering
Receptor Regulation of Cell Function
Biomedical Engineering
Molecular Engineering
Therapeutics Development and Delivery
Cell and Tissue Engineering
Physiological Modeling
Therapeutic Gene Biotechnology
Biomolecular Engineering
Dupont/MIT Alliance (DMA)
Cell Signaling and Cell Biology
Computational and Systems Biology
Computational Modeling of Biological and Physiological Systems
Cell, Tissue and Biomolecular Engineering
Immunoassays

Research Summary

Molecular cell bioengineering: the application of engineering approaches to develop quantitative understanding of cell function in terms of fundamental molecular properties, and to apply this understanding for improved design of cell-based technologies. The group focuses on elucidating important aspects of receptor-mediated regulation of mammalian blood and tissue cell behavioral functions such as proliferation, adhesion, migration, and macromolecular transport. A central paradigm of the work is development and testing of mechanistic models -- based on principles from engineering analysis and synthesis -- for receptor regulation of cell function by exploiting techniques of molecular biology to alter parameters characterizing receptor or ligand properties in well-characterized cell systems. Quantitative experimental assays are used to measure cell function and receptor/ligand interaction parameters. Problems are motivated by health care technologies of interest to pharmaceutical and biotechnological companies.

Professor Lauffenburger is also collaborating with the Tidor group to design improved protein therapeutics, including cytokines and antibodies, based on computational modeling across the combined molecular and cellular level.

Recent Work